Regulatory Twitter Goes '#Rogue' With AltFDA
Executive Summary
Underground Twitter feed for FDA starts out slow compared to fellow agencies.
You may also be interested in...
US FDA’s Bipartisan Support May Offer Shelter From Political Winds, Former Chief Says
In the wake of 21st Century Cures legislation, next commissioner will have strong support across party lines to undertake smarter regulation aimed at improving the efficiency of the drug development process, former FDA head McClellan says.
FDA Commissioner Candidate Gulfo Hates Breakthrough, Wants To Reevaluate User Fees
In an interview, Joseph Gulfo, former medtech industry CEO and vocal FDA critic, outlines his worldview and interest in pushing aggressively against increasing the FDA ‘body of law.’
A Burning FDA Hiring Freeze Question: What About User Fee-Supported Staff?
Industry worries about user fee programs as US FDA could wait weeks before finding out how President Trump's hiring freeze affects it.